|
|
||||||||
Articles |
-Aminobutyric Acid (GABA) Transaminase in Isolated Leukocytes and Evidence That GABA and ß-Alanine Transaminases Are Identical
1
Metabolic Unit, Department of Clinical Chemistry, University Hospital Vrije Universiteit, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
2
Department of Molecular and Medical Genetics,
Biochemical Genetics Laboratory, Oregon Health Sciences University,
Portland, OR 97201.
a Author for correspondence. Fax 31-20-4440305; e-mail
C.Jakobs{at}azvu.nl.
Background: Several methods have been published for measuring
-aminobutyric acid transaminase (GABA-T) activity, but these methods
are either impracticable because of the use of radioisotopes or
insufficiently sensitive to determine small enzyme activities in
leukocyte extracts. We developed a direct and sensitive enzyme method.
Methods: We developed a stable-isotope dilution method for the
measurement of [15N]glutamic acid derived from
[15N]GABA and
-ketoglutaric acid, catalyzed by
GABA-T. The method for analysis of [15N]glutamic acid
comprised a solid-phase extraction procedure to isolate this analyte
from incubation samples. After derivatization,
[15N]glutamic acid was quantified by gas
chromatographymass spectrometry relative to its
2H5-labeled internal standard. In addition to
[15N]GABA, [15N]ß-alanine was a
cosubstrate.
Results: GABA-T-deficient lymphoblasts showed diminished enzyme activity, with both [15N]GABA and [15N]ß-alanine as substrate. Vigabatrin inhibited the enzyme activity for both substrates.
Conclusions: The activity of GABA-T can be accurately determined by our procedure using 15N-labeled substrate, measuring the formation of [15N]glutamic acid. Our results with [15N]ß-alanine indicate that GABA and ß-alanine transaminases are identical.
The following articles in journals at HighWire Press have cited this article:
![]() |
C. Wang, K. Kerckhofs, M. Van de Casteele, I. Smolders, D. Pipeleers, and Z. Ling Glucose inhibits GABA release by pancreatic beta-cells through an increase in GABA shunt activity Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E494 - E499. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B.P. van Kuilenburg, R. Meinsma, E. Beke, B. Assmann, A. Ribes, I. Lorente, R. Busch, E. Mayatepek, N. G.G.M. Abeling, A. van Cruchten, et al. {beta}-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities Hum. Mol. Genet., November 15, 2004; 13(22): 2793 - 2801. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Struys, N. M. Verhoeven, B. Roos, and C. Jakobs Disease-related Metabolites in Culture Medium of Fibroblasts from Patients with D-2-Hydroxyglutaric Aciduria, L-2-Hydroxyglutaric Aciduria, and Combined D/L-2-Hydroxyglutaric Aciduria Clin. Chem., July 1, 2003; 49(7): 1133 - 1138. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |